Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,661 public trials 325 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Active, Not Recruiting

Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)

NCT02899052

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama at Birmingham - Main /ID# 151405 Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences /ID# 151399 Little Rock, Arkansas, United States
  • Memorial Healthcare System /ID# 224862 Hollywood, Florida, United States
  • Winship Cancer Institute of Emory University /ID# 161710 Atlanta, Georgia, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

NCT05123131

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Beaumont Hospital Dublin, Ireland
  • Mater Misericordiae University Hospital Dublin, Ireland
  • St James's Hospital Dublin, Ireland
View Trial Details
Active, Not Recruiting

Multiple Myeloma Molecular Monitoring Study

NCT03421132

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Active, Not Recruiting

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT03539744

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407 Tucson, Arizona, United States
  • VA Central California Health Care System /ID# 200047 Fresno, California, United States
  • University of California, Los Angeles /ID# 171524 Los Angeles, California, United States
  • Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 222904 Aurora, Colorado, United States
View all 180 locations
View Trial Details
Active, Not Recruiting

Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma

NCT03190525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • S. Orsola Malpighi Bologna, Italy
  • Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy
  • ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO Cagliari, Italy
View all 35 locations
View Trial Details
Active, Not Recruiting

Study of 3D189 in Patients With Hematologic Malignancies

NCT05320809

Conditions
Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital Of Nanchang University Nanchang, Jiangxi, China
  • Shengjing Hospital of China Medical Shengyang, Liaoning, China
  • Blood Disease Hospital , Chinese Academy of Medical Science Tianjing, China
View Trial Details
Active, Not Recruiting

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

NCT03376672

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Helsinki University Central Hospital Helsinki, Finland
  • Central Finland Central Hospital Jyväskylä, Finland
  • Kainuu Central Hospital Kajaani, Finland
  • Kymenlaakso Central Hospital Kotka, Finland
View all 26 locations
View Trial Details

Related conditions